Scientists, Ethicists Debate Future of Gene Editing
By Karen Pallarito,
HealthDay
| 12. 02. 2015
[cites CGS' Marcy Darnovsky]
Untitled Document
What if faulty genes in your DNA could be easily corrected, avoiding the ravages of diseases like cystic fibrosis or certain cancers?
That is the promise of gene editing, a new technique being heralded as an enormous advancement in genetic engineering.
Scientists say its speed, efficiency and cost-effectiveness make it an excellent tool for replacing rogue genes that cause human suffering and early death.
But worries about the technology’s darker side have mounted ever since Chinese researchers in April reported results of an experiment to edit a defective gene in a human embryo. For ethical reasons, researchers say they used an abnormal embryo.
The team concluded that gene editing isn’t yet sufficiently reliable and precise enough to apply the technique in humans.
Nevertheless, some scientists and bioethicists worry that gene editing may be used one day to create “designer babies” and forever alter the human genome.
Experts from around the globe are gathered in Washington, D.C., this week to discuss the clinical potential and ethical pitfalls of human gene editing. The three-day international summit, convened by the U.S...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...